Emergent BioSolution, a biopharmaceutical company, launches Emergard, a ruggedized, military-grade auto-injector. It is designed for intra-muscular self-injection of antidotes and is used during medical treatments....  more>>
Monday, August 10, 2015
SeraCare Life Sciences, a partner to in vitro diagnostics manufacturers announces an alliance with ViveBio, a biotechnology company to market and sell their combined technologies into the in- vitro diagnostic development (IVD) market....  more>>
Tuesday, August 11, 2015
Opterra II offers real-time improvement in imaging speed, sensitivity, fluorescence intensity and resolution to develop experimental conditions across an array of life science research areas....  more>>
Thursday, August 20, 2015
Oncology start-ups: Guardant Health and Flatiron Health partner against Cancer using Big Data and Analytics. The team will be generating a database of relevant genomic information, clinical trials and drug treatment results with the sole purpose of accelerating the development of new cancer drugs....  more>>
Friday, August 28, 2015
Providerof Global consulting services and solutions, The Windshire Group announces the launch of its new service Stabilityshire. Stabilityshire is a drug stability and shelf-life data analysis, assessment, reporting and management service....  more>>
Monday, September 21, 2015
Qognify has recently released Situator 8.0 with the introduction of the new Operational Intelligence Centre (OIC)....  more>>
Wednesday, March 23, 2016
DuPont Industrial Biosciences make a smart move by taking over the enzyme and technology assets from Dyadic International. The agreement also includes the purchase of C1 platform - a fungal expression technology for producing enzymes....  more>>
Friday, November 13, 2015
The promise of personalized medicine is becoming a reality generating notable improvements in human health and the potential to reduce the socioeconomic burden of disease in recent times....  more>>
Tuesday, December 22, 2015
A new pledge has been announced in biotechnology industry: International Stem Cell Corporation, a biotechnology company, has entered into a clinical research agreement with the Florey Institute of Neuroscience and Mental Health to conduct a Phase I/IIa clinical trial, dose escalation trails of human Parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC) that are intracranialy transplanted into in Parkinson’s disease patients. ...  more>>
Thursday, December 31, 2015
ERT, a cloud platform solutions provider for clinical data analytics, has selected Planbox’s Innovation Management Software–Platform Innovate–as its innovation management platform....  more>>
Friday, February 5, 2016
<<Previous  1   2   3   Next>>